Results: 1-25 | 26-50 | 51-59

Table of contents of journal: *Cancer biotherapy & radiopharmaceuticals

Results: 1-25/59

Authors: Oldham, RK
Citation: Rk. Oldham, Fundamentally different, CANC BIO R, 14(6), 1999, pp. 413-415

Authors: Schillaci, O Scopinaro, F
Citation: O. Schillaci et F. Scopinaro, Tc-99m sestamibi scintimammography: Where is it now?, CANC BIO R, 14(6), 1999, pp. 417-422

Authors: Dillman, RO
Citation: Ro. Dillman, What to do with IL-2?, CANC BIO R, 14(6), 1999, pp. 423-434

Authors: Kakuda, JT Stuntz, ME Vargas, HI Khalkhali, I
Citation: Jt. Kakuda et al., Status of scintimammography and its relationship to other detection methods for breast cancer, CANC BIO R, 14(6), 1999, pp. 435-442

Authors: Dillman, RO Nayak, SK Brown, JV Mahdavi, K Beutel, LD
Citation: Ro. Dillman et al., The feasibility of using short-term cultures of ovarian cancer cells for use as autologous tumor cell vaccines as adjuvant treatment of advanced ovarian cancer, CANC BIO R, 14(6), 1999, pp. 443-449

Authors: Saleh, MN Raisch, KP Stackhouse, MA Grizzle, WE Bonner, JA Mayo, MS Kim, HG Meredith, RF Wheeler, RH Buchsbaum, DJ
Citation: Mn. Saleh et al., Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation, CANC BIO R, 14(6), 1999, pp. 451-463

Authors: Contasta, I Berghella, AM Pellegrini, P Del Beato, T Casciani, CU Adorno, D
Citation: I. Contasta et al., Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network, CANC BIO R, 14(6), 1999, pp. 465-475

Authors: Paganelli, G Zoboli, S Cremonesi, M Macke, HR Chinol, M
Citation: G. Paganelli et al., Receptor-mediated radionuclide therapy with Y-90-DOTA-D-Phe(1)-Tyr(3)-octreotide: Preliminary report in cancer patients, CANC BIO R, 14(6), 1999, pp. 477-483

Authors: Line, BR Feustel, PJ Festin, SM Andersen, TT Dansereau, RN Lukasiewicz, RL Zhu, SJ Bennett, JA
Citation: Br. Line et al., Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein, CANC BIO R, 14(6), 1999, pp. 485-494

Authors: Aziz, A Hashmi, R Ogawa, Y Hayashi, K
Citation: A. Aziz et al., Tc-99m-MIBI scintimammography; SPECT versus planar imaging, CANC BIO R, 14(6), 1999, pp. 495-500

Authors: Rasey, JS
Citation: Js. Rasey, Amifostine, CANC BIO R, 14(5), 1999, pp. 331-335

Authors: Bohuslavizki, KH Klutmann, S Jenicke, L Kroger, S Buchert, R Mester, J Clausen, M
Citation: Kh. Bohuslavizki et al., Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioicacid (amifostine) in high-dose radioiodine treatment: Results obtained in a rabbit animal model and in a double-blind multi-arm trial, CANC BIO R, 14(5), 1999, pp. 337-347

Authors: Aviles, A Halabe, J
Citation: A. Aviles et J. Halabe, Improved prognosis in patients with acquired immunodeficiency syndrome-related lymphoma, CANC BIO R, 14(5), 1999, pp. 349-352

Authors: Xiang, J
Citation: J. Xiang, Expression of co-stimulatory 4-1BB ligand induces significant tumor regression and protective immunity, CANC BIO R, 14(5), 1999, pp. 353-361

Authors: Kukis, DL DeNardo, SJ Mills, SL Shen, S O'Donnell, RT DeNardo, GL
Citation: Dl. Kukis et al., Stability of monoclonal antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 immunoconjugate with ultra freezer storage, CANC BIO R, 14(5), 1999, pp. 363-369

Authors: Kennel, SJ Lankford, TK Foote, LJ Davis, IA Boll, RA Mirzadeh, S
Citation: Sj. Kennel et al., Combination vascular targeted and tumor targeted radioimmunotherapy, CANC BIO R, 14(5), 1999, pp. 371-379

Authors: Breitz, HB Fisher, DR Goris, ML Knox, S Ratliff, B Murtha, AD Weiden, PL
Citation: Hb. Breitz et al., Radiation absorbed dose estimation for Y-90-DOTA-biotin with pretargeted NR-LU-10/streptavidin, CANC BIO R, 14(5), 1999, pp. 381-395

Authors: Schepetkin, I Cherdyntseva, N Afanasjev, S Antipov, S Zyryanov, B
Citation: I. Schepetkin et al., The luminol-amplified chemiluminescence of neutrophils and monocytes in patients with gastric cancer after intraoperative radiotherapy using radiosensitizer sanazole, CANC BIO R, 14(5), 1999, pp. 397-402

Authors: Kamei, H Koide, T Koijima, T Hashimoto, Y Hasegawa, M
Citation: H. Kamei et al., Effect of gold on tumor-associated antigens, CANC BIO R, 14(5), 1999, pp. 403-406

Authors: Silverman, S DeNardo, GL Siegel, E
Citation: S. Silverman et al., Determination of spleen size by scintigraphy, CANC BIO R, 14(5), 1999, pp. 407-411

Authors: DeNardo, GL
Citation: Gl. Denardo, About the old and the new: Gallium-67 scintigraphy to rituximab for lymphoma, CANC BIO R, 14(4), 1999, pp. 235-236

Authors: Schilder, R
Citation: R. Schilder, Rituximab immunotherapy, CANC BIO R, 14(4), 1999, pp. 237-240

Authors: White, CA
Citation: Ca. White, Rituximab immunotherapy for non-Hodgkin's lymphoma, CANC BIO R, 14(4), 1999, pp. 241-250

Authors: Rehm, PK
Citation: Pk. Rehm, Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma, CANC BIO R, 14(4), 1999, pp. 251-262

Authors: O'Neill, HC Jonas, N Wilson, H Ni, K
Citation: Hc. O'Neill et al., Immunotherapeutic potential of dendritic cells generated in long term stroma-dependent cultures, CANC BIO R, 14(4), 1999, pp. 263-276
Risultati: 1-25 | 26-50 | 51-59